<code id='F61A1A111A'></code><style id='F61A1A111A'></style>
    • <acronym id='F61A1A111A'></acronym>
      <center id='F61A1A111A'><center id='F61A1A111A'><tfoot id='F61A1A111A'></tfoot></center><abbr id='F61A1A111A'><dir id='F61A1A111A'><tfoot id='F61A1A111A'></tfoot><noframes id='F61A1A111A'>

    • <optgroup id='F61A1A111A'><strike id='F61A1A111A'><sup id='F61A1A111A'></sup></strike><code id='F61A1A111A'></code></optgroup>
        1. <b id='F61A1A111A'><label id='F61A1A111A'><select id='F61A1A111A'><dt id='F61A1A111A'><span id='F61A1A111A'></span></dt></select></label></b><u id='F61A1A111A'></u>
          <i id='F61A1A111A'><strike id='F61A1A111A'><tt id='F61A1A111A'><pre id='F61A1A111A'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:4
          Adobe

          Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

          Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

          advertisement

          Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more
          Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi
          Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Georgia court denies Trump's request to quash DA's 2020 election probe

          0:23FormerPresidentDonaldTrumpspeaksatTrumpNationalGolfClubinBedminster,N.J.,June13,2023.AndrewHarni